Jean‐François Yale

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects

Jay S. Skyler, Ruth S. Weinstock, Philip Raskin et al. · Diabetes Care · 2005 · 271 citations · Full text

Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management

Lawrence A. Leiter, Jean‐François Yale, Jean‐Louis Chiasson et al. · 2005 · 202 citations

Psychological Co-morbidities, Behavioral Medicine, Social Sciences +4

Diabetes and Mental Health

David J. Robinson, Michael James Coons, Heidi Haensel et al. · Canadian Journal of Diabetes · 2018 · 195 citations

Psychiatry, Diabetes, Depression +4